We are led by a team with deep, relevant experience for developing novel therapeutics that address large unmet needs for people with neurological disorders.

Joe Blanchard, MBA

Board Director & Advisor

Michel Baudry, PhD

Chief Scientific Advisor

Francesco Salituro, PhD

Preclinical Drug Development

Shujaath Mehdi, PhD

Biochemical Pharmacology

Philippe Bey, PhD


Kathy Fosnaugh, PhD

Program Management

Scientific & clinical Advisors

 Ramon Diaz-Arrastia, MD, PhD

 Presidential Professor of Neurology and Director of Clinical Traumatic Brain Injury (TBI) Research
University of Pennsylvania Perelman School of Medicine

Imad Najm, MD

 Director, Epilepsy Center

Cleveland Clinic

Barry Jordan, MD, MPH

Chief Medical Officer

Rancho Los Amigos National Rehabilitation Center

Michael Palfreyman, PhD

Palfreyman BioPharm Advisors, LLC